💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Curis, Inc. (CRIS)
« Back to company indexCRIS Chatter Timeline
Stock Ticker for CRIS
Most Active Tweeters for CRIS
| User | Tweets |
|---|---|
| @FefferCapital | 32 |
| @SteelyRivers | 20 |
| @nolastevedore | 11 |
| @AnExpertOne1 | 10 |
| @PersimmonTI | 7 |
Recent Tweets for CRIS
 |
@YuZhu4 RT @PersimmonTI: Examples of how the sun my come up, at some point in the indeterminate future: $TRIL - 4/28 R&D Day $CRIS - 4948 update @… 3:04am |
 |
@MarcJacksonLA $CRIS Curis Receives FDA Orphan Drug Designation For CA4948 For AML & MDS https://t.co/r1Yyuujojq 2:04am |
 |
@PersimmonTI Examples of how the sun my come up, at some point in the indeterminate future: $TRIL - 4/28 R&D Day $CRIS - 4948 u… https://t.co/zvOd4PYnxW April 19th 2021, 11:04pm |
 |
@MaisaCorp $CRIS said Monday the US Food and Drug Administration has granted an orphan drug designation for CA-4948, a small m… https://t.co/KePPSjt7MO April 19th 2021, 11:04pm |
 |
@SteelyRivers @TargetedOnc @srqstockpicker I think Tik-Tok Finance thinks this is a jail sentence. $CRIS April 19th 2021, 9:04pm |
 |
@FefferCapital Just get it over with and hit 9 $CRIS April 19th 2021, 7:04pm |
 |
@RVH_Investing Morons whoever bought these. They’re getting smoked. The next big $cris options bet just short big https://t.co/CybnKvxDOT April 19th 2021, 7:04pm |
 |
@lbblazej @lblegend33 $AFMD holding the line. I doubled up last week. Then doubled up on $CRIS is morning. Seeing some recov… https://t.co/67qorpV62l April 19th 2021, 6:04pm |
 |
@dmshetayh being stupid and bought more $cris April 19th 2021, 5:04pm |
|
@lbblazej @lblegend33 Added $CRIS here. April 19th 2021, 5:04pm |
 |
@Gambiste1 RT @EAlkovac: Anyone knows why $CRIS is dropping like plane from the sky?? I need answers! April 19th 2021, 5:04pm |
 |
@EAlkovac Anyone knows why $CRIS is dropping like plane from the sky?? I need answers! April 19th 2021, 4:04pm |
 |
@SmallCapsDaily $CRIS Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS PR Newswire -6.96%… https://t.co/Ng2ZGPmyxp April 19th 2021, 3:04pm |
 |
@mediasentiment $CRIS new alert at https://t.co/A7qrDaJkzw #stocks #daytrading #NYSE #NASDAQ #market 618 April 19th 2021, 2:04pm |
 |
@AnExpertOne1 $CRIS Amazing, nearly 10% down on no bad news at all - glad I only have a small position, but still, makes no sens… https://t.co/bQmjbq1e2W April 19th 2021, 2:04pm |
 |
@keitrader RT @Briefingcom: $CRIS: Curis confirms it received FDA Orphan Drug Designation for CA-4948 for the treatment of AML and MDS https://t.co/Cf… April 19th 2021, 2:04pm |
|
@FefferCapital Wait.. $CRIS is getting a bid? No way April 19th 2021, 2:04pm |
|
@FefferCapital Looks like we're going to 9 today $CRIS fml https://t.co/5CkHYrtURh April 19th 2021, 2:04pm |
 |
@Briefingcom $CRIS: Curis confirms it received FDA Orphan Drug Designation for CA-4948 for the treatment of AML and MDS https://t.co/CfpPk4jgEy April 19th 2021, 2:04pm |
|
@FefferCapital Why am I long $CRIS again? April 19th 2021, 1:04pm |
 |
@Frankisphere $CRIS - Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS https://t.co/2AcfvFzxDY via @Yahoo April 19th 2021, 1:04pm |
 |
@SelfThink4 $CRIS This ODD designation news is from last Friday. Still good news April 19th 2021, 1:04pm |
 |
@biostockinfo RT @BioStocks: $CRIS Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS April 19th 2021, 12:04pm |
 |
@QuantData Curis Receives FDA Orphan Drug Designation For CA-4948 For The Treatment Of AML and MDS Related Tickers: $CRIS Rea… https://t.co/Gh7xGMBLJv April 19th 2021, 12:04pm |
|
@PersimmonTI $CRIS Finally PRs 4948 OTDs in AML & MDS: https://t.co/Gk9xRS7U6m April 19th 2021, 12:04pm |
 |
@sbwcws Curis receives FDA orphan drug designation for CA-4948 $CRIS April 19th 2021, 12:04pm |
 |
@Allstocknews $CRIS Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS From our Stock News Alerts App April 19th 2021, 12:04pm |
 |
@Bios_n_Techs $CRIS (+3.5% PM) Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS April 19th 2021, 12:04pm |
 |
@James__BondOO7 RT @stock_titan: $CRIS Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS https://t.co/ErGmMDVdST April 19th 2021, 12:04pm |
 |
@BehaviorFin $CRIS Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS https://t.co/kyQI9aBxtm April 19th 2021, 12:04pm |
 |
@BioStocks $CRIS Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS April 19th 2021, 12:04pm |
 |
@OpenOutcrier $CRIS (+3.5% pre) Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS - SI https://t.co/U4qHZjaGRk April 19th 2021, 12:04pm |
 |
@stock_titan $CRIS Curis Receives FDA Orphan Drug Designation for CA-4948 for the Treatment of AML and MDS https://t.co/ErGmMDVdST April 19th 2021, 12:04pm |
 |
@cherrylaldave RT @bio_breakthroug: $KZIA Given the parabolic move in shares of Curis $CRIS on extremely early data on a tiny # of patients, how high do s… April 19th 2021, 11:04am |
 |
@bio_breakthroug $KZIA Market cap should (and soon will) be well over 5x $CRIS market cap, not the other way around. April 19th 2021, 10:04am |
|
@bio_breakthroug $KZIA Given the parabolic move in shares of Curis $CRIS on extremely early data on a tiny # of patients, how high d… https://t.co/m8DYddVcM4 April 19th 2021, 5:04am |
|
@thomasmarciano Bought $CRIS AH Friday...looking for a pop on the Orphan Drug PR and if there’s no PR still think I’ll hold on for… https://t.co/UvsvD1du0S April 19th 2021, 12:04am |
 |
@Danny_Dollars_ How do you think $CRIS will react to the orphan drug status news? April 18th 2021, 10:04pm |
 |
@ShortAlgoTrades $CRIS Now waiting for Short signal. https://t.co/Ty71AhiueU April 18th 2021, 4:04pm |
 |
@EZMoney_41 $CRIS Now waiting for Short signal. https://t.co/eBou5Bi3OP April 18th 2021, 4:04pm |
 |
@askwarrenbuffet $CRIS To Be Scooped Up In All Cash Transaction By Unnamed Nasdaq Traded Company, Official PR Coming Early Next Week… https://t.co/eFfAXbPee3 April 18th 2021, 5:04am |
 |
@nolastevedore @PersimmonTI $CRIS Here's another April 2021 article on VISTA. Love how the title of the paper says in its headlin… https://t.co/CZCWVXZ1Gh April 17th 2021, 6:04pm |
|
@nolastevedore @PersimmonTI CA-4948, $CRIS IRAK4 asset, gets most attention, but the company's VISTA molecule, CI-8993, is intrigu… https://t.co/bxEY17HjFk April 17th 2021, 6:04pm |
 |
@Dreesenkl @jmbiofarm @Bilalbadman Hey Jordan. Doing some dd on $CLRB. WM data looks great (I am in $CRIS, which, it seems, ha… https://t.co/AUi92v321A April 17th 2021, 6:04pm |
|
@Dreesenkl @PersimmonTI Question: doing some dd and I came across $CLRB. Their WM data seems better than $CRIS data. ORR 100%,… https://t.co/eYdks5wJcd April 17th 2021, 6:04pm |
 |
@BruceLeefromTT RT @PersimmonTI: $CRIS Have tweeted bout BO prospects b4 & always a guessing game, in any case. However, the case for BO pre/concurrent… April 17th 2021, 6:04pm |
|
@PersimmonTI $CRIS Have tweeted bout BO prospects b4 & always a guessing game, in any case. However, the case for BO pre/conc… https://t.co/9O5kkGg9G2 April 17th 2021, 6:04pm |
 |
@major_mosby @WillyMeatsauce1 At least they are off the screen. I had to stare at CRIS puts one month out expire worthless. All my homies hate $CRIS April 17th 2021, 5:04pm |
 |
@LifeSciFocus RT @PersimmonTI: $CRIS First, no PR about 4948 ODD in AML, and now no company PR about ODD in MDS... ? H/t @BioRunUpAlerts https://t.co/… April 17th 2021, 3:04pm |
|
@PersimmonTI $CRIS First, no PR about 4948 ODD in AML, and now no company PR about ODD in MDS... ? H/t @BioRunUpAlerts https://t.co/mfZi5EkYbf April 17th 2021, 2:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
